Low or undetectable numbers of Philadelphia chromosome-positive leukemic stem cells (Ph(+)CD34(+)CD38(neg)) in chronic myeloid leukemia patients in complete cytogenetic remission after tyrosine kinase inhibitor therapy
- PMID: 19776759
- DOI: 10.1038/leu.2009.190
Low or undetectable numbers of Philadelphia chromosome-positive leukemic stem cells (Ph(+)CD34(+)CD38(neg)) in chronic myeloid leukemia patients in complete cytogenetic remission after tyrosine kinase inhibitor therapy
Similar articles
-
Early in vivo changes of the transcriptome in Philadelphia chromosome-positive CD34+ cells from patients with chronic myelogenous leukaemia following imatinib therapy.Leukemia. 2009 May;23(5):983-5. doi: 10.1038/leu.2008.337. Epub 2008 Dec 4. Leukemia. 2009. PMID: 19052557 No abstract available.
-
Gene expression profiling of Philadelphia chromosome (Ph)-negative CD34+ hematopoietic stem and progenitor cells of patients with Ph-positive CML in major molecular remission during therapy with imatinib.Leukemia. 2005 Mar;19(3):458-60. doi: 10.1038/sj.leu.2403615. Leukemia. 2005. PMID: 15618956 No abstract available.
-
Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies.Leukemia. 2007 May;21(5):926-35. doi: 10.1038/sj.leu.2404609. Epub 2007 Mar 1. Leukemia. 2007. PMID: 17330101
-
Applying the discovery of the Philadelphia chromosome.J Clin Invest. 2007 Aug;117(8):2067-74. doi: 10.1172/JCI31988. J Clin Invest. 2007. PMID: 17671641 Free PMC article. Review.
-
[Imatinib therapy for patients with chronic myelogenous leukemia].Gan To Kagaku Ryoho. 2005 Mar;32(3):297-303. Gan To Kagaku Ryoho. 2005. PMID: 15791812 Review. Japanese.
Cited by
-
Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia.PLoS One. 2017 Jan 30;12(1):e0171041. doi: 10.1371/journal.pone.0171041. eCollection 2017. PLoS One. 2017. PMID: 28135325 Free PMC article.
-
Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease.Blood. 2011 Sep 29;118(13):3657-60. doi: 10.1182/blood-2011-02-335497. Epub 2011 Jul 25. Blood. 2011. PMID: 21791426 Free PMC article.
-
Pushing the limits of targeted therapy in chronic myeloid leukaemia.Nat Rev Cancer. 2012 Jul 24;12(8):513-26. doi: 10.1038/nrc3317. Nat Rev Cancer. 2012. PMID: 22825216 Review.
-
Philadelphia chromosome-positive leukemia stem cells in acute lymphoblastic leukemia and tyrosine kinase inhibitor therapy.World J Stem Cells. 2012 Jun 26;4(6):44-52. doi: 10.4252/wjsc.v4.i6.44. World J Stem Cells. 2012. PMID: 22993661 Free PMC article.
-
Desmoplastic small round cell tumor cancer stem cell-like cells resist chemotherapy but remain dependent on the EWSR1-WT1 oncoprotein.Front Cell Dev Biol. 2022 Nov 25;10:1048709. doi: 10.3389/fcell.2022.1048709. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36506091 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials